Search clinical trials for: Ergoferon
Total 39 results
-
Materia Medica HoldingCompletedAcute Respiratory Viral InfectionsRussian Federation, Kazakhstan
-
Materia Medica HoldingCompletedViral Intestinal InfectionRussian Federation, Uzbekistan
-
Materia Medica HoldingCompletedImmunization Against COVID-19Russian Federation
-
Materia Medica HoldingCompletedAcute Upper Respiratory Tract InfectionsRussian Federation
-
Materia Medica HoldingCompletedViral Respiratory Infection
-
Materia Medica HoldingCompletedAcute Upper Respiratory Tract InfectionsRussian Federation
-
West Virginia UniversityCompletedMusculoskeletal Pain | Sedentary Lifestyle | Musculoskeletal StrainUnited States
-
Loughborough UniversityBradford Teaching Hospitals NHS Foundation TrustCompletedObesity | Physical Activity | Child Behavior | Sedentary Behavior | Health Behavior
-
Allina Health SystemCompleted
-
Brunel UniversityPublic Health England; Macmillan Canceer Support; ErgotronCompletedPhysical ActivityUnited Kingdom
-
Materia Medica HoldingCompletedInfluenzaRussian Federation
-
Materia Medica HoldingCompletedInfluenzaRussian Federation
-
University of ThessalyCompletedOxidative Stress | Muscle Damage
-
M.D. Anderson Cancer CenterWithdrawn
-
National Cancer Institute (NCI)Completed
-
Duke UniversityTerminated
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | LeukemiaPuerto Rico, United States, Switzerland, Canada
-
National Taiwan University HospitalCompletedEnd Stage Renal Disease | Chronic Hepatitis CTaiwan
-
Hoffmann-La RocheNordic Lymphoma GroupCompleted
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Hoffmann-La RocheCompletedRenal Cell CancerItaly, Spain, Germany, Switzerland, Russian Federation, Czech Republic, France, United Kingdom, Belgium, Singapore, Hungary, Poland, Israel, Taiwan, Australia, Finland, Netherlands, Norway
-
PfizerCompletedCarcinoma, Renal CellUnited States, Canada, Spain, Australia, Germany, Italy, Russian Federation, Brazil, France, United Kingdom, Poland
-
M.D. Anderson Cancer CenterSchering-PloughCompleted
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
University of TurkuCompletedMetastatic MelanomaFinland
-
University of BirminghamNovartis; National Cancer Institute, France; MPN VoiceRecruitingPolycythemia VeraUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
University Hospital TuebingenCompletedPanuveitis | Posterior Uveitis | Retinal Vasculitis | Behcet's DiseaseGermany
-
National Cancer Institute (NCI)CompletedStage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedSorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Papillary Renal Cell CarcinomaUnited States
-
The University of Texas Health Science Center,...UnknownPancreatic NeoplasmsUnited States
-
Central European Society for Anticancer Drug ResearchCompletedMetastatic Renal Cell CarcinomaGermany
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
M.D. Anderson Cancer CenterSchering-PloughCompleted
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States